CARBOPLATIN

CARBOPLATIN was reported 130075 times

CARBOPLATIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IMMUNE-MEDIATED HYPERTHYROIDISM 85 0.3346
1 CERVIX CARCINOMA RECURRENT 55 0.3090
2 RADIATION OESOPHAGITIS 114 0.2992
3 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 219 0.2748
4 PSEUDOCELLULITIS 56 0.2617
5 IMMUNE-MEDIATED HYPOTHYROIDISM 286 0.2535
6 IMMUNE-MEDIATED NEPHRITIS 112 0.2388
7 RENAL SALT-WASTING SYNDROME 92 0.2347
8 IMMUNE-MEDIATED DERMATITIS 234 0.2321
9 MENINGITIS TUBERCULOUS 125 0.2236
10 UROGENITAL FISTULA 52 0.2194
11 IMMUNE-MEDIATED HYPOPHYSITIS 97 0.2151
12 IMMUNE-MEDIATED LUNG DISEASE 375 0.2055
13 LACRIMAL STRUCTURE INJURY 70 0.1857
14 IMMUNE-MEDIATED HEPATIC DISORDER 359 0.1839
15 IMMUNE-MEDIATED THYROIDITIS 88 0.1781
16 IMMUNE-MEDIATED HEPATITIS 363 0.1776
17 IMMUNE-MEDIATED RENAL DISORDER 73 0.1763
18 IMMUNE-MEDIATED PANCREATITIS 67 0.1759
19 IMMUNE-MEDIATED ARTHRITIS 62 0.1627
20 GLUCOCORTICOID DEFICIENCY 67 0.1584
21 IMMUNE-MEDIATED ENTEROCOLITIS 567 0.1540
22 IMMUNE-MEDIATED CHOLANGITIS 54 0.1504
23 RADIATION PNEUMONITIS 318 0.1485
24 NON-SMALL CELL LUNG CANCER 699 0.1458
25 IMMUNE-MEDIATED ENCEPHALITIS 76 0.1437
26 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 135 0.1426
27 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 125 0.1424
28 EGFR GENE MUTATION 53 0.1417
29 NON-SMALL CELL LUNG CANCER METASTATIC 124 0.1411
30 OTOTOXICITY 259 0.1399
31 NEUTROPENIC SEPSIS 942 0.1318
32 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 289 0.1309
33 FEBRILE BONE MARROW APLASIA 547 0.1286
34 OVARIAN CANCER METASTATIC 106 0.1247
35 OVARIAN CANCER RECURRENT 199 0.1238
36 IMMUNE-MEDIATED MYOCARDITIS 196 0.1213
37 HAEMATOTOXICITY 1086 0.1142
38 MYELOSUPPRESSION 4107 0.1139
39 MALIGNANT TRANSFORMATION 51 0.1136
40 AORTITIS 77 0.1122
41 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 136 0.1091
42 RECALL PHENOMENON 91 0.1089
43 LICHENOID KERATOSIS 241 0.1054
44 AUTOIMMUNE COLITIS 67 0.1039
45 FEBRILE NEUTROPENIA 6744 0.1016
46 LYMPHANGIOSIS CARCINOMATOSA 104 0.0998
47 HYPOPHYSITIS 200 0.0994
48 NEUTROPENIC INFECTION 94 0.0982
49 INFUSION RELATED HYPERSENSITIVITY REACTION 59 0.0982
50 THERAPY PARTIAL RESPONDER 1532 0.0981
51 HYPOPITUITARISM 168 0.0965
52 NEUTROPENIC COLITIS 193 0.0932
53 SUPERIOR VENA CAVA SYNDROME 56 0.0927
54 METASTASES TO MENINGES 210 0.0923
55 TUMOUR PSEUDOPROGRESSION 99 0.0904
56 SMALL CELL LUNG CANCER 135 0.0893
57 METASTASES TO ADRENALS 79 0.0856
58 SKIN TOXICITY 483 0.0854
59 METASTASES TO PLEURA 89 0.0848
60 BICYTOPENIA 165 0.0841
61 MYASTHENIC SYNDROME 64 0.0827
62 TRACHEO-OESOPHAGEAL FISTULA 52 0.0814
63 RADIATION SKIN INJURY 94 0.0810
64 BONE MARROW TOXICITY 96 0.0810
65 GASTROINTESTINAL TOXICITY 385 0.0801
66 PARANEOPLASTIC SYNDROME 54 0.0799
67 SQUAMOUS CELL CARCINOMA OF LUNG 61 0.0795
68 ACQUIRED GENE MUTATION 104 0.0793
69 METASTASES TO PERITONEUM 198 0.0783
70 MALIGNANT PLEURAL EFFUSION 132 0.0782
71 NEOPLASM RECURRENCE 264 0.0778
72 PALMAR ERYTHEMA 88 0.0763
73 MUCOSAL INFLAMMATION 2000 0.0763
74 CYTOPENIA 926 0.0756
75 PERIPHERAL SENSORY NEUROPATHY 442 0.0755
76 LUNG ADENOCARCINOMA 223 0.0740
77 METASTASES TO SKIN 76 0.0736
78 GRANULOCYTE COUNT DECREASED 135 0.0727
79 IMMUNE-MEDIATED ADVERSE REACTION 111 0.0723
80 TUMOUR NECROSIS 75 0.0710
81 ENTEROCOLITIS INFECTIOUS 65 0.0704
82 NEUTROPHIL COUNT DECREASED 2841 0.0696
83 APLASIA 136 0.0694
84 PANCYTOPENIA 3857 0.0689
85 RADIOTHERAPY 131 0.0684
86 HEPATIC CYTOLYSIS 861 0.0675
87 ENCEPHALITIS AUTOIMMUNE 86 0.0654
88 LYMPHADENOPATHY MEDIASTINAL 125 0.0652
89 DEVICE RELATED THROMBOSIS 64 0.0649
90 FULMINANT TYPE 1 DIABETES MELLITUS 66 0.0640
91 NEPHRITIS 213 0.0637
92 METASTASES TO CENTRAL NERVOUS SYSTEM 811 0.0628
93 MYELODYSPLASTIC SYNDROME 906 0.0626
94 THYROIDITIS 188 0.0625
95 HAIR DISORDER 515 0.0624
96 MALIGNANT NEOPLASM PROGRESSION 6347 0.0619
97 ACUTE MYELOID LEUKAEMIA 959 0.0615
98 DACRYOSTENOSIS ACQUIRED 79 0.0611
99 NEUTROPHIL COUNT ABNORMAL 172 0.0608
100 PERIPHERAL MOTOR NEUROPATHY 85 0.0606
101 SECONDARY ADRENOCORTICAL INSUFFICIENCY 90 0.0596
102 HYPOMAGNESAEMIA 826 0.0593
103 SMALL INTESTINAL PERFORATION 111 0.0591
104 ASPERGILLUS INFECTION 384 0.0584
105 PSYCHOLOGICAL TRAUMA 504 0.0583
106 FOLLICULAR LYMPHOMA 51 0.0580
107 RENAL TUBULAR DISORDER 161 0.0572
108 PELVIC ABSCESS 65 0.0566
109 ACUTE PROMYELOCYTIC LEUKAEMIA 58 0.0564
110 METASTASES TO LYMPH NODES 380 0.0562
111 BONE MARROW FAILURE 1144 0.0562
112 NEUTROPENIA 7634 0.0561
113 PNEUMONITIS 1517 0.0557
114 SECOND PRIMARY MALIGNANCY 463 0.0556
115 THROMBOCYTOPENIA 6084 0.0543
116 GASTROINTESTINAL PERFORATION 226 0.0543
117 TUMOUR LYSIS SYNDROME 474 0.0538
118 ADRENAL INSUFFICIENCY 643 0.0529
119 CORTISOL DECREASED 60 0.0525
120 METASTASES TO LUNG 604 0.0522
121 OESOPHAGITIS 571 0.0522
122 DISEASE PROGRESSION 6173 0.0521
123 HYPERTRANSAMINASAEMIA 360 0.0517
124 PULMONARY TOXICITY 357 0.0504
125 ADMINISTRATION SITE EXTRAVASATION 50 0.0501
126 ALOPECIA AREATA 87 0.0495
127 SUBILEUS 102 0.0489
128 NEOPLASM PROGRESSION 1703 0.0489
129 HAIR COLOUR CHANGES 609 0.0489
130 VENOOCCLUSIVE LIVER DISEASE 241 0.0488
131 MADAROSIS 565 0.0486
132 ENTEROCOLITIS 281 0.0486
133 FEMALE GENITAL TRACT FISTULA 83 0.0486
134 POLYNEUROPATHY 579 0.0483
135 FANCONI SYNDROME 68 0.0481
136 INFECTIOUS PLEURAL EFFUSION 73 0.0479
137 METASTASES TO LIVER 834 0.0474
138 CHOLANGITIS SCLEROSING 97 0.0472
139 SYSTEMIC INFECTION 77 0.0464
140 CULTURE URINE POSITIVE 65 0.0462
141 MYOCARDITIS 530 0.0462
142 AUTOIMMUNE HAEMOLYTIC ANAEMIA 157 0.0458
143 LEUKOPENIA 2291 0.0458
144 VENA CAVA THROMBOSIS 76 0.0457
145 HAIR TEXTURE ABNORMAL 610 0.0456
146 TYPE I HYPERSENSITIVITY 160 0.0454
147 METASTASES TO BONE 744 0.0453
148 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 80 0.0449
149 VENOOCCLUSIVE DISEASE 112 0.0447
150 JUGULAR VEIN THROMBOSIS 79 0.0444
151 METASTATIC NEOPLASM 191 0.0442
152 CARDIOTOXICITY 392 0.0439
153 PULMONARY SEPSIS 63 0.0433
154 AORTIC THROMBOSIS 49 0.0424
155 ADENOCARCINOMA 95 0.0424
156 EXTREMITY NECROSIS 73 0.0418
157 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 314 0.0418
158 METASTASIS 294 0.0411
159 ADRENOCORTICAL INSUFFICIENCY ACUTE 80 0.0410
160 HYDRONEPHROSIS 304 0.0406
161 HYPOPROTEINAEMIA 77 0.0405
162 HYPERTHYROIDISM 584 0.0403
163 CANCER PAIN 103 0.0403
164 PARONYCHIA 177 0.0402
165 GENE MUTATION 79 0.0399
166 HYPOTHYROIDISM 1268 0.0397
167 ASPARTATE AMINOTRANSFERASE ABNORMAL 60 0.0394
168 DIFFUSE LARGE B-CELL LYMPHOMA 302 0.0392
169 THROMBOTIC MICROANGIOPATHY 381 0.0391
170 LUNG CONSOLIDATION 109 0.0389
171 ANAEMIA 7389 0.0387
172 HYPOTHALAMO-PITUITARY DISORDER 56 0.0384
173 ONYCHOLYSIS 60 0.0384
174 BLOOD CULTURE POSITIVE 114 0.0380
175 HYPOALBUMINAEMIA 296 0.0380
176 PERFORMANCE STATUS DECREASED 177 0.0379
177 METASTASES TO SPINE 127 0.0378
178 CAPILLARY LEAK SYNDROME 77 0.0372
179 COLITIS 1402 0.0369
180 LARGE INTESTINE PERFORATION 256 0.0368
181 PNEUMATOSIS INTESTINALIS 105 0.0368
182 INTERSTITIAL LUNG DISEASE 1780 0.0367
183 CYSTITIS HAEMORRHAGIC 148 0.0367
184 DERMATITIS ACNEIFORM 223 0.0366
185 LUNG ABSCESS 76 0.0362
186 IMMUNE-MEDIATED MYOSITIS 99 0.0359
187 HYPOKALAEMIA 1652 0.0358
188 CHOLANGITIS 221 0.0356
189 CYTOKINE RELEASE SYNDROME 715 0.0356
190 IMMUNE THROMBOCYTOPENIA 162 0.0353
191 EMBOLISM VENOUS 107 0.0352
192 EMPYEMA 70 0.0352
193 BLOOD CHLORIDE DECREASED 90 0.0349
194 BREAST CANCER RECURRENT 108 0.0342
195 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 325 0.0340
196 PNEUMONIA PSEUDOMONAL 52 0.0339
197 TUBULOINTERSTITIAL NEPHRITIS 632 0.0337
198 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 346 0.0337
199 TUMOUR HAEMORRHAGE 96 0.0336
200 STEM CELL TRANSPLANT 84 0.0336
201 MYELITIS 52 0.0335
202 NEPHROPATHY TOXIC 368 0.0328
203 EMBOLISM 272 0.0327
204 SEPTIC SHOCK 1425 0.0327
205 DERMATOMYOSITIS 82 0.0323
206 ADRENAL DISORDER 62 0.0323
207 OVARIAN CANCER 297 0.0322
208 MYOSITIS 289 0.0322
209 VENOUS THROMBOSIS 126 0.0321
210 ENCEPHALITIS 221 0.0319
211 ESCHERICHIA BACTERAEMIA 75 0.0319
212 SUSPECTED OFF LABEL USE 144 0.0318
213 PROTEINURIA 605 0.0318
214 MASTECTOMY 55 0.0314
215 APLASTIC ANAEMIA 164 0.0314
216 CARBOHYDRATE ANTIGEN 125 INCREASED 107 0.0313
217 ESCHERICHIA SEPSIS 90 0.0310
218 BREAST CANCER METASTATIC 332 0.0309
219 CYTOMEGALOVIRUS CHORIORETINITIS 60 0.0307
220 LEFT VENTRICULAR DYSFUNCTION 206 0.0307
221 OPTIC ATROPHY 50 0.0307
222 PERIPHERAL ISCHAEMIA 125 0.0306
223 RASH MACULO-PAPULAR 680 0.0305
224 VENOUS THROMBOSIS LIMB 63 0.0305
225 ILEUS 379 0.0305
226 LUNG OPACITY 80 0.0303
227 LUNG CANCER METASTATIC 87 0.0302
228 DIVERTICULAR PERFORATION 62 0.0301
229 ATELECTASIS 291 0.0301
230 ANAPHYLACTIC SHOCK 769 0.0298
231 RENAL TUBULAR NECROSIS 292 0.0297
232 NEUROPATHY PERIPHERAL 2820 0.0296
233 MIXED LIVER INJURY 89 0.0295
234 DERMATITIS BULLOUS 214 0.0295
235 ALANINE AMINOTRANSFERASE ABNORMAL 62 0.0294
236 HAEMOLYTIC URAEMIC SYNDROME 67 0.0289
237 AGRANULOCYTOSIS 535 0.0288
238 NEUROTOXICITY 504 0.0287
239 DEAFNESS NEUROSENSORY 94 0.0286
240 ENTERITIS 182 0.0284
241 GUILLAIN-BARRE SYNDROME 137 0.0283
242 RECURRENT CANCER 115 0.0282
243 PNEUMOTHORAX 444 0.0280
244 ARTERIAL THROMBOSIS 54 0.0279
245 SMALL INTESTINAL OBSTRUCTION 343 0.0278
246 HYPOCALCAEMIA 524 0.0277
247 PAPILLOEDEMA 125 0.0277
248 PULMONARY HAEMORRHAGE 215 0.0275
249 HEPATOTOXICITY 610 0.0274
250 TYPE 1 DIABETES MELLITUS 165 0.0274
251 FAILURE TO THRIVE 142 0.0273
252 CLOSTRIDIUM DIFFICILE COLITIS 290 0.0273
253 STRESS CARDIOMYOPATHY 159 0.0273
254 INVASIVE DUCTAL BREAST CARCINOMA 74 0.0272
255 DIASTOLIC DYSFUNCTION 84 0.0272
256 HAEMOPTYSIS 757 0.0271
257 CARCINOEMBRYONIC ANTIGEN INCREASED 52 0.0268
258 DRUG RESISTANCE 689 0.0268
259 INTESTINAL PERFORATION 300 0.0267
260 TROPONIN INCREASED 202 0.0265
261 ORAL INTAKE REDUCED 64 0.0264
262 ERYTHEMA MULTIFORME 246 0.0263
263 ENDOMETRIAL CANCER 58 0.0263
264 TOXIC SKIN ERUPTION 265 0.0263
265 SYSTEMIC CANDIDA 66 0.0263
266 PLEURAL EFFUSION 1592 0.0261
267 CARDIAC TAMPONADE 124 0.0261
268 BACTERAEMIA 309 0.0260
269 OESOPHAGEAL STENOSIS 74 0.0260
270 OSTEOLYSIS 53 0.0259
271 DYSAESTHESIA 79 0.0257
272 STAPHYLOCOCCUS TEST POSITIVE 54 0.0256
273 PLATELET COUNT DECREASED 2725 0.0255
274 ELECTROLYTE IMBALANCE 296 0.0255
275 HYPOVOLAEMIA 149 0.0254
276 ORGANISING PNEUMONIA 126 0.0254
277 EJECTION FRACTION DECREASED 395 0.0254
278 HYPERAEMIA 50 0.0254
279 HYPOPHOSPHATAEMIA 186 0.0251
280 PSEUDOMEMBRANOUS COLITIS 56 0.0251
281 HEPATIC FUNCTION ABNORMAL 931 0.0249
282 SEPSIS 2782 0.0249
283 UROSEPSIS 230 0.0249
284 LYMPHOPENIA 352 0.0249
285 CACHEXIA 128 0.0249
286 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 95 0.0248
287 GASTROINTESTINAL NECROSIS 71 0.0243
288 DERMATITIS EXFOLIATIVE GENERALISED 84 0.0241
289 BLOOD LACTATE DEHYDROGENASE INCREASED 381 0.0240
290 THROMBOCYTOSIS 88 0.0240
291 DISSEMINATED INTRAVASCULAR COAGULATION 338 0.0240
292 HAEMOLYTIC ANAEMIA 215 0.0240
293 BLOOD ALBUMIN DECREASED 190 0.0239
294 LEUKOENCEPHALOPATHY 89 0.0239
295 HYPERPYREXIA 101 0.0238
296 HEPATIC LESION 103 0.0238
297 WHITE BLOOD CELL COUNT DECREASED 2582 0.0238
298 HEPATITIS 607 0.0237
299 ASCITES 697 0.0237
300 DIABETES INSIPIDUS 57 0.0237
301 AUTOIMMUNE HEPATITIS 161 0.0231
302 CLOSTRIDIUM TEST POSITIVE 51 0.0231
303 LICHEN PLANUS 53 0.0228
304 VITREOUS HAEMORRHAGE 63 0.0228
305 BONE LESION 82 0.0227
306 HYPOXIA 795 0.0226
307 CEREBRAL ISCHAEMIA 116 0.0225
308 HYPONATRAEMIA 1269 0.0225
309 COLITIS ISCHAEMIC 150 0.0222
310 LYMPHOCYTE COUNT DECREASED 393 0.0222
311 TOXIC EPIDERMAL NECROLYSIS 337 0.0222
312 ODYNOPHAGIA 132 0.0221
313 OESOPHAGEAL CANDIDIASIS 88 0.0221
314 HEPATITIS B REACTIVATION 70 0.0220
315 KOUNIS SYNDROME 50 0.0220
316 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 51 0.0219
317 BRONCHOSPASM 311 0.0218
318 WOUND DEHISCENCE 73 0.0216
319 CHOLESTASIS 413 0.0215
320 URINARY TRACT OBSTRUCTION 51 0.0215
321 STAPHYLOCOCCAL SEPSIS 106 0.0214
322 HYPERTHERMIA 163 0.0213
323 PERICARDIAL EFFUSION 493 0.0213
324 LARYNGOSPASM 57 0.0212
325 GRANULOCYTOPENIA 119 0.0209
326 ACUTE LYMPHOCYTIC LEUKAEMIA 59 0.0208
327 TYPE IV HYPERSENSITIVITY REACTION 57 0.0208
328 TRANSAMINASES INCREASED 462 0.0208
329 VENTRICULAR DYSFUNCTION 53 0.0204
330 HAEMOGLOBIN ABNORMAL 131 0.0203
331 ATRIAL FLUTTER 161 0.0202
332 LUNG INFILTRATION 178 0.0201
333 CLOSTRIDIAL INFECTION 68 0.0201
334 THROMBOTIC THROMBOCYTOPENIC PURPURA 70 0.0198
335 RESPIRATORY FAILURE 1443 0.0198
336 STAPHYLOCOCCAL BACTERAEMIA 86 0.0198
337 HEPATIC CYST 67 0.0197
338 NON-CARDIAC CHEST PAIN 62 0.0196
339 AZOTAEMIA 78 0.0195
340 AMYLASE INCREASED 72 0.0195
341 HYPERBILIRUBINAEMIA 202 0.0195
342 MULTIPLE-DRUG RESISTANCE 60 0.0193
343 DYSPNOEA AT REST 56 0.0193
344 NORMOCHROMIC NORMOCYTIC ANAEMIA 58 0.0193
345 PNEUMONIA BACTERIAL 177 0.0193
346 PYELONEPHRITIS 167 0.0193
347 ABDOMINAL ABSCESS 85 0.0192
348 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 446 0.0191
349 SINUS TACHYCARDIA 271 0.0191
350 INTESTINAL ISCHAEMIA 105 0.0190
351 FAECALOMA 104 0.0190
352 MENINGITIS ASEPTIC 85 0.0189
353 ISCHAEMIA 87 0.0189
354 DRUG TOLERANCE DECREASED 53 0.0189
355 GENERAL PHYSICAL HEALTH DETERIORATION 2181 0.0188
356 PNEUMOCYSTIS JIROVECII PNEUMONIA 189 0.0188
357 CARDIAC DYSFUNCTION 70 0.0188
358 AREFLEXIA 50 0.0187
359 DISEASE RECURRENCE 888 0.0186
360 FIBRIN D DIMER INCREASED 66 0.0185
361 BACTERIAL SEPSIS 60 0.0184
362 ENTEROCOCCAL INFECTION 89 0.0184
363 HYPOVOLAEMIC SHOCK 88 0.0184
364 ENCEPHALOPATHY 449 0.0183
365 DRUG ERUPTION 324 0.0183
366 SUPRAVENTRICULAR TACHYCARDIA 175 0.0183
367 PROSTATE CANCER METASTATIC 61 0.0182
368 BONE MARROW DISORDER 55 0.0182
369 BLOOD CREATININE DECREASED 57 0.0182
370 INFUSION RELATED REACTION 1205 0.0182
371 EXTRAVASATION 74 0.0180
372 PULMONARY EMBOLISM 1711 0.0180
373 KLEBSIELLA INFECTION 91 0.0180
374 ACUTE KIDNEY INJURY 2737 0.0179
375 LYMPHOEDEMA 123 0.0178
376 ENDOCARDITIS 91 0.0177
377 GROWTH RETARDATION 52 0.0176
378 NECROSIS 98 0.0176
379 ANAPHYLACTOID REACTION 72 0.0175
380 ASPARTATE AMINOTRANSFERASE INCREASED 929 0.0175
381 THROMBOPHLEBITIS 61 0.0174
382 ALANINE AMINOTRANSFERASE INCREASED 1068 0.0174
383 DEHYDRATION 2312 0.0173
384 ILEUS PARALYTIC 77 0.0172
385 HAEMATOCRIT DECREASED 342 0.0172
386 STOMATITIS 1045 0.0172
387 PLATELET COUNT ABNORMAL 104 0.0172
388 PATHOLOGICAL FRACTURE 87 0.0171
389 HICCUPS 140 0.0170
390 MULTIPLE ORGAN DYSFUNCTION SYNDROME 483 0.0170
391 ESCHERICHIA INFECTION 139 0.0169
392 NEPHROTIC SYNDROME 115 0.0168
393 HYDROCEPHALUS 91 0.0167
394 SPINAL CORD COMPRESSION 65 0.0167
395 ACUTE RESPIRATORY DISTRESS SYNDROME 295 0.0167
396 AUTOIMMUNE THYROIDITIS 63 0.0166
397 CATHETER SITE INFECTION 63 0.0166
398 PULSE ABSENT 79 0.0166
399 PULMONARY ALVEOLAR HAEMORRHAGE 93 0.0166
400 ORAL CANDIDIASIS 218 0.0165
401 DUODENAL ULCER 116 0.0164
402 PURPURA 145 0.0164
403 FIBROSIS 50 0.0162
404 HYPERCALCAEMIA 200 0.0162
405 BLOOD MAGNESIUM DECREASED 139 0.0161
406 CARDIAC FAILURE ACUTE 107 0.0160
407 TUMOUR MARKER INCREASED 77 0.0160
408 TACHYPNOEA 218 0.0160
409 MALNUTRITION 179 0.0160
410 GAMMA-GLUTAMYLTRANSFERASE INCREASED 354 0.0160
411 RESPIRATORY DISTRESS 440 0.0159
412 LUNG NEOPLASM 68 0.0159
413 ACUTE RESPIRATORY FAILURE 306 0.0159
414 C-REACTIVE PROTEIN INCREASED 572 0.0157
415 MONOCYTE COUNT INCREASED 57 0.0157
416 HYPERURICAEMIA 64 0.0156
417 DEEP VEIN THROMBOSIS 1011 0.0155
418 NAIL DISORDER 136 0.0155
419 INFLAMMATORY MARKER INCREASED 77 0.0155
420 ESCHERICHIA URINARY TRACT INFECTION 66 0.0155
421 CARDIOMYOPATHY 228 0.0154
422 MENINGITIS 103 0.0154
423 RED CELL DISTRIBUTION WIDTH INCREASED 64 0.0154
424 DEVICE RELATED INFECTION 236 0.0153
425 HAEMOGLOBIN DECREASED 1570 0.0153
426 BLOOD ALKALINE PHOSPHATASE INCREASED 379 0.0152
427 BLOOD THYROID STIMULATING HORMONE DECREASED 69 0.0152
428 DIVERTICULUM INTESTINAL 66 0.0151
429 RENAL FAILURE CHRONIC 116 0.0151
430 BRONCHOPULMONARY ASPERGILLOSIS 116 0.0149
431 DERMATITIS 312 0.0149
432 OXYGEN SATURATION DECREASED 832 0.0148
433 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 122 0.0148
434 ANAPHYLACTIC REACTION 815 0.0147
435 BLOOD CREATININE INCREASED 959 0.0147
436 LEUKOCYTOSIS 263 0.0145
437 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 86 0.0145
438 PYREXIA 4984 0.0144
439 RENAL IMPAIRMENT 1209 0.0144
440 HYPOPHAGIA 367 0.0143
441 PSEUDOMONAS INFECTION 123 0.0143
442 SKIN REACTION 201 0.0143
443 BLOOD BILIRUBIN INCREASED 385 0.0142
444 NECROTISING FASCIITIS 50 0.0142
445 HEPATITIS ACUTE 92 0.0141
446 EPISTAXIS 1057 0.0141
447 ACUTE CORONARY SYNDROME 117 0.0141
448 WHITE BLOOD CELL COUNT ABNORMAL 90 0.0141
449 DRUG-INDUCED LIVER INJURY 441 0.0140
450 HYPERTRIGLYCERIDAEMIA 82 0.0140
451 SUDDEN DEATH 148 0.0140
452 PULMONARY FIBROSIS 268 0.0140
453 RETINOPATHY 52 0.0139
454 VASCULAR DEVICE INFECTION 63 0.0139
455 SHOCK HAEMORRHAGIC 113 0.0139
456 HYPERNATRAEMIA 69 0.0138
457 CEREBRAL ATROPHY 55 0.0138
458 NEUTROPHIL COUNT INCREASED 141 0.0138
459 ERYSIPELAS 69 0.0137
460 PHLEBITIS 70 0.0137
461 POLYARTHRITIS 72 0.0136
462 FLUID INTAKE REDUCED 68 0.0136
463 HYPOGAMMAGLOBULINAEMIA 89 0.0135
464 LYMPHADENOPATHY 478 0.0135
465 LARYNGEAL OEDEMA 83 0.0135
466 RASH PUSTULAR 98 0.0134
467 IMPAIRED QUALITY OF LIFE 193 0.0134
468 OESOPHAGEAL PAIN 53 0.0134
469 PULMONARY MASS 198 0.0133
470 HEPATITIS CHOLESTATIC 80 0.0133
471 SARCOIDOSIS 63 0.0132
472 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 103 0.0132
473 NAIL DISCOLOURATION 52 0.0132
474 COVID-19 PNEUMONIA 156 0.0132
475 ALOPECIA 2586 0.0132
476 FOETAL GROWTH RESTRICTION 80 0.0131
477 HEPATOCELLULAR INJURY 186 0.0131
478 BLOOD UREA INCREASED 219 0.0131
479 CERVIX CARCINOMA 51 0.0130
480 TACHYCARDIA 1159 0.0130
481 ACUTE PULMONARY OEDEMA 73 0.0130
482 MYASTHENIA GRAVIS 105 0.0130
483 LIP OEDEMA 55 0.0130
484 CEREBRAL INFARCTION 317 0.0130
485 CANDIDIASIS 52 0.0130
486 CHOLECYSTITIS 154 0.0129
487 DECREASED APPETITE 2991 0.0129
488 LIPASE INCREASED 98 0.0128
489 HEPATIC FAILURE 385 0.0128
490 ATRIAL FIBRILLATION 1241 0.0127
491 OLIGURIA 79 0.0127
492 DEAFNESS 332 0.0127
493 BLOOD SODIUM DECREASED 239 0.0127
494 VASCULITIS 147 0.0126
495 LOCALISED OEDEMA 58 0.0125
496 HAEMATURIA 428 0.0125
497 NEUTROPHILIA 71 0.0125
498 NEOPLASM 142 0.0123
499 CYANOSIS 194 0.0123
500 DRUG TOXICITY 168 0.0123
501 SHOCK 282 0.0122
502 LUNG INFECTION 190 0.0122
503 ATAXIA 145 0.0122
504 MOUTH ULCERATION 257 0.0122
505 CIRCULATORY COLLAPSE 207 0.0121
506 LEFT VENTRICULAR HYPERTROPHY 52 0.0121
507 EMPHYSEMA 122 0.0121
508 DYSPNOEA EXERTIONAL 454 0.0120
509 CONGESTIVE CARDIOMYOPATHY 50 0.0120
510 FLANK PAIN 112 0.0119
511 FLUSHING 1208 0.0119
512 HYPERTENSIVE CRISIS 132 0.0119
513 ANOREXIA 152 0.0118
514 PERIORBITAL OEDEMA 61 0.0117
515 BLOOD CREATINE INCREASED 52 0.0117
516 MENTAL STATUS CHANGES 326 0.0117
517 ISCHAEMIC STROKE 209 0.0117
518 RENAL FAILURE ACUTE 496 0.0117
519 ABDOMINAL TENDERNESS 58 0.0117
520 BLOOD PRESSURE SYSTOLIC DECREASED 53 0.0116
521 PROTEIN URINE PRESENT 58 0.0116
522 HYPERKALAEMIA 406 0.0116
523 OSTEONECROSIS OF JAW 285 0.0115
524 DYSPHAGIA 1087 0.0114
525 HYPOTENSION 2293 0.0114
526 SKIN NECROSIS 59 0.0114
527 CYTOMEGALOVIRUS INFECTION 188 0.0113
528 VOMITING 5279 0.0112
529 HYPERGLYCAEMIA 409 0.0112
530 RESPIRATORY TRACT INFECTION 292 0.0112
531 INFECTION 1622 0.0112
532 DERMATITIS EXFOLIATIVE 56 0.0112
533 BRAIN OEDEMA 141 0.0112
534 BLOOD THYROID STIMULATING HORMONE INCREASED 102 0.0111
535 PERITONITIS 229 0.0110
536 PROCTALGIA 71 0.0110
537 THERAPY NON-RESPONDER 496 0.0110
538 METABOLIC DISORDER 64 0.0110
539 PRODUCT USE IN UNAPPROVED INDICATION 2719 0.0110
540 HERPES SIMPLEX 71 0.0109
541 DIARRHOEA HAEMORRHAGIC 102 0.0109
542 URINE OUTPUT DECREASED 95 0.0109
543 ERYTHEMA 2233 0.0109
544 FACE OEDEMA 183 0.0108
545 MULTI-ORGAN FAILURE 187 0.0108
546 MYOCARDIAL ISCHAEMIA 123 0.0108
547 PETECHIAE 112 0.0107
548 ASTHENIA 4026 0.0107
549 EYELID PTOSIS 108 0.0106
550 GENERAL PHYSICAL CONDITION ABNORMAL 72 0.0106
551 PNEUMONIA 3435 0.0106
552 ASPIRATION 116 0.0106
553 FISTULA 119 0.0106
554 PNEUMONIA ASPIRATION 262 0.0105
555 STEVENS-JOHNSON SYNDROME 233 0.0105
556 BLOOD LACTIC ACID INCREASED 55 0.0104
557 IMMUNOSUPPRESSION 92 0.0104
558 BONE PAIN 610 0.0104
559 NEUROLOGICAL SYMPTOM 59 0.0103
560 RENAL FAILURE 1365 0.0103
561 TOXIC ENCEPHALOPATHY 52 0.0103
562 CONSTIPATION 2214 0.0101
563 BLOOD CALCIUM DECREASED 114 0.0101
564 LIVER INJURY 248 0.0101
565 ABDOMINAL PAIN 2344 0.0101
566 OFF LABEL USE 8814 0.0101
567 APHTHOUS ULCER 78 0.0100
568 BODY TEMPERATURE INCREASED 205 0.0100
569 LIVER DISORDER 445 0.0100
570 GENERALISED OEDEMA 124 0.0100
571 UNRESPONSIVE TO STIMULI 258 0.0100
572 GASTRITIS 263 0.0100
573 DIARRHOEA 6424 0.0099
574 DYSPNOEA 5533 0.0098
575 CANDIDA INFECTION 165 0.0098
576 ANURIA 84 0.0098
577 RED BLOOD CELL COUNT DECREASED 279 0.0097
578 LUNG DISORDER 477 0.0097
579 CHOLECYSTITIS ACUTE 55 0.0097
580 RENAL CYST 77 0.0097
581 CARDIO-RESPIRATORY ARREST 405 0.0097
582 PANCREATITIS ACUTE 217 0.0096
583 HEPATITIS B 57 0.0094
584 SKIN DISORDER 315 0.0094
585 PEMPHIGOID 71 0.0094
586 DELIRIUM 326 0.0094
587 ACIDOSIS 71 0.0093
588 INTESTINAL OBSTRUCTION 349 0.0092
589 CHEST DISCOMFORT 941 0.0092
590 THYROID DISORDER 141 0.0091
591 WOUND INFECTION 100 0.0091
592 NAUSEA 7206 0.0091
593 ANGIOPATHY 51 0.0091
594 ACUTE MYOCARDIAL INFARCTION 266 0.0090
595 ALTERED STATE OF CONSCIOUSNESS 195 0.0090
596 HEMIPARESIS 152 0.0090
597 DECUBITUS ULCER 73 0.0089
598 OEDEMA 485 0.0089
599 PLEURISY 53 0.0089
600 MITRAL VALVE INCOMPETENCE 101 0.0089
601 SUBARACHNOID HAEMORRHAGE 90 0.0088
602 BRONCHIECTASIS 59 0.0087
603 POST PROCEDURAL COMPLICATION 168 0.0087
604 BLOOD DISORDER 70 0.0087
605 RETINAL HAEMORRHAGE 62 0.0087
606 PROTHROMBIN TIME PROLONGED 52 0.0087
607 SPINAL OSTEOARTHRITIS 76 0.0086
608 CARDIAC FAILURE 694 0.0086
609 CLOSTRIDIUM DIFFICILE INFECTION 186 0.0085
610 EYELID OEDEMA 99 0.0085
611 SKIN HYPERPIGMENTATION 73 0.0085
612 STAPHYLOCOCCAL INFECTION 280 0.0085
613 ASPHYXIA 69 0.0084
614 MELAENA 186 0.0084
615 SYNCOPE 840 0.0084
616 RETINAL DETACHMENT 77 0.0084
617 BACTERIAL INFECTION 156 0.0084
618 GRAFT VERSUS HOST DISEASE 60 0.0083
619 ACUTE HEPATIC FAILURE 114 0.0083
620 BLOOD POTASSIUM DECREASED 248 0.0082
621 HEPATOMEGALY 81 0.0082
622 GASTROENTERITIS 120 0.0082
623 ORTHOSTATIC HYPOTENSION 142 0.0081
624 FEELING HOT 499 0.0081
625 MYOPATHY 70 0.0081
626 OEDEMA PERIPHERAL 984 0.0081
627 ATRIOVENTRICULAR BLOCK COMPLETE 54 0.0081
628 RHINITIS 65 0.0081
629 TRICUSPID VALVE INCOMPETENCE 64 0.0080
630 LYMPHOMA 124 0.0080
631 BLOOD PRESSURE DIASTOLIC DECREASED 59 0.0080
632 ONYCHOCLASIS 55 0.0080
633 THROAT TIGHTNESS 215 0.0079
634 CHILLS 927 0.0079
635 HAEMOLYSIS 61 0.0079
636 HAEMORRHAGE INTRACRANIAL 118 0.0079
637 HYPERSENSITIVITY 1462 0.0079
638 PERICARDITIS 132 0.0078
639 LOWER GASTROINTESTINAL HAEMORRHAGE 58 0.0078
640 REFUSAL OF TREATMENT BY PATIENT 51 0.0078
641 VENTRICULAR EXTRASYSTOLES 81 0.0078
642 NO THERAPEUTIC RESPONSE 95 0.0078
643 DERMATITIS ALLERGIC 98 0.0078
644 TASTE DISORDER 158 0.0078
645 GASTRIC ULCER 148 0.0078
646 SQUAMOUS CELL CARCINOMA 73 0.0077
647 CELLULITIS 389 0.0077
648 PLATELET COUNT INCREASED 100 0.0077
649 ABSCESS 122 0.0076
650 HYPERTENSION 1619 0.0076
651 LEUKAEMIA 72 0.0076
652 PRODUCTIVE COUGH 364 0.0076
653 RASH 3311 0.0076
654 VENTRICULAR FIBRILLATION 84 0.0076
655 BLOOD PRESSURE DECREASED 502 0.0075
656 HAEMODYNAMIC INSTABILITY 57 0.0075
657 CHEST PAIN 1379 0.0074
658 DYSURIA 274 0.0074
659 LACRIMATION INCREASED 224 0.0074
660 WHITE BLOOD CELL COUNT INCREASED 283 0.0074
661 COLD SWEAT 130 0.0074
662 MUSCULOSKELETAL CHEST PAIN 114 0.0074
663 PALLOR 200 0.0073
664 HAEMATEMESIS 186 0.0073
665 DIABETIC KETOACIDOSIS 176 0.0073
666 PULMONARY ARTERIAL HYPERTENSION 106 0.0073
667 LOW BIRTH WEIGHT BABY 58 0.0073
668 NERVOUS SYSTEM DISORDER 227 0.0073
669 PRESYNCOPE 176 0.0072
670 SPINAL COMPRESSION FRACTURE 59 0.0071
671 CARDIAC ARREST 588 0.0071
672 MOUTH HAEMORRHAGE 52 0.0071
673 GENERALISED TONIC-CLONIC SEIZURE 117 0.0071
674 CARDIOGENIC SHOCK 101 0.0070
675 NEURALGIA 171 0.0070
676 HYPOTONIA 70 0.0070
677 URINARY TRACT INFECTION 1191 0.0070
678 GINGIVAL BLEEDING 95 0.0070
679 JAUNDICE 187 0.0069
680 ORAL PAIN 154 0.0069
681 OROPHARYNGEAL DISCOMFORT 62 0.0069
682 VENTRICULAR TACHYCARDIA 113 0.0068
683 HAEMORRHAGE 715 0.0068
684 ARTERIOSCLEROSIS 64 0.0068
685 RECTAL HAEMORRHAGE 291 0.0068
686 UPPER GASTROINTESTINAL HAEMORRHAGE 113 0.0067
687 EPILEPSY 203 0.0066
688 DIVERTICULITIS 184 0.0066
689 CENTRAL NERVOUS SYSTEM LESION 91 0.0066
690 BODY TEMPERATURE DECREASED 65 0.0066
691 APHASIA 199 0.0066
692 LIVER FUNCTION TEST INCREASED 141 0.0066
693 DEPRESSED LEVEL OF CONSCIOUSNESS 258 0.0065
694 LUNG NEOPLASM MALIGNANT 268 0.0065
695 GROIN PAIN 57 0.0065
696 TOXICITY TO VARIOUS AGENTS 1082 0.0064
697 METABOLIC ACIDOSIS 205 0.0064
698 STATUS EPILEPTICUS 72 0.0064
699 HEMIPLEGIA 53 0.0064
700 POLYURIA 52 0.0063
701 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 347 0.0063
702 URINARY RETENTION 211 0.0063
703 COAGULOPATHY 105 0.0063
704 COUGH 1754 0.0062
705 RESPIRATORY DISORDER 187 0.0062
706 RASH ERYTHEMATOUS 298 0.0062
707 MASS 87 0.0062
708 HEPATIC ENCEPHALOPATHY 58 0.0062
709 FATIGUE 4835 0.0062
710 TRANSFUSION 65 0.0062
711 PARAESTHESIA 963 0.0061
712 FOLLICULITIS 64 0.0061
713 PULMONARY OEDEMA 273 0.0061
714 DYSGEUSIA 450 0.0061
715 HAEMORRHOIDS 118 0.0060
716 ABDOMINAL PAIN LOWER 150 0.0059
717 GASTROINTESTINAL HAEMORRHAGE 494 0.0059
718 DRUG INTOLERANCE 568 0.0059
719 CYSTITIS 187 0.0059
720 NEPHROPATHY 54 0.0058
721 CEREBRAL HAEMORRHAGE 207 0.0058
722 LIVER FUNCTION TEST ABNORMAL 168 0.0058
723 BLOOD CREATINE PHOSPHOKINASE INCREASED 166 0.0058
724 TREATMENT FAILURE 475 0.0057
725 SPINAL PAIN 67 0.0057
726 PULMONARY HYPERTENSION 119 0.0057
727 CONFUSIONAL STATE 922 0.0057
728 NODULE 74 0.0057
729 OSTEONECROSIS 186 0.0057
730 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 295 0.0056
731 BONE DISORDER 103 0.0056
732 GASTROINTESTINAL DISORDER 506 0.0056
733 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 400 0.0056
734 SKIN LESION 154 0.0056
735 SINUS BRADYCARDIA 54 0.0056
736 THERAPEUTIC RESPONSE DECREASED 335 0.0055
737 PELVIC PAIN 100 0.0055
738 LOSS OF CONSCIOUSNESS 702 0.0055
739 URINARY INCONTINENCE 162 0.0055
740 CARDIOMEGALY 67 0.0054
741 SENSORY DISTURBANCE 87 0.0054
742 HYPERHIDROSIS 696 0.0054
743 DIPLOPIA 140 0.0054
744 SKIN ULCER 138 0.0053
745 BACK PAIN 1227 0.0053
746 MUSCULAR WEAKNESS 600 0.0053
747 FEEDING DISORDER 107 0.0053
748 ANGINA PECTORIS 151 0.0053
749 INTERNATIONAL NORMALISED RATIO INCREASED 150 0.0053
750 SKIN INFECTION 59 0.0053
751 HAEMATOMA 136 0.0052
752 HERPES ZOSTER 300 0.0052
753 GASTRIC HAEMORRHAGE 60 0.0052
754 MUSCULOSKELETAL PAIN 273 0.0052
755 THROMBOSIS 419 0.0052
756 TENDERNESS 54 0.0052
757 INTENTIONAL PRODUCT USE ISSUE 450 0.0051
758 PULMONARY CONGESTION 67 0.0051
759 OSTEOMYELITIS 92 0.0051
760 DEATH 4377 0.0051
761 LETHARGY 290 0.0050
762 RASH PRURITIC 273 0.0050
763 PERIPHERAL COLDNESS 69 0.0050
764 DISORIENTATION 199 0.0050
765 MOTOR DYSFUNCTION 51 0.0050
766 INFLAMMATION 257 0.0050
767 IMPAIRED HEALING 163 0.0050
768 GLOMERULAR FILTRATION RATE DECREASED 61 0.0050
769 WEIGHT DECREASED 1382 0.0049
770 COGNITIVE DISORDER 231 0.0049
771 DRUG INTERACTION 772 0.0049
772 PRURITUS 1870 0.0049
773 MYALGIA 824 0.0048
774 SPLENOMEGALY 56 0.0048
775 HEPATIC STEATOSIS 89 0.0048
776 DYSARTHRIA 179 0.0048
777 INCONTINENCE 50 0.0047
778 ARRHYTHMIA 224 0.0047
779 PREMATURE BABY 142 0.0047
780 HOT FLUSH 355 0.0047
781 HYPOAESTHESIA 705 0.0047
782 PARALYSIS 67 0.0047
783 PREMATURE DELIVERY 74 0.0046
784 RESPIRATORY ARREST 128 0.0046
785 SEIZURE 536 0.0046
786 ELECTROCARDIOGRAM QT PROLONGED 166 0.0046
787 EATING DISORDER 98 0.0046
788 HEPATIC ENZYME INCREASED 312 0.0046
789 DYSPHONIA 267 0.0046
790 OBSTRUCTIVE AIRWAYS DISORDER 50 0.0045
791 TINNITUS 206 0.0045
792 PARAESTHESIA ORAL 64 0.0044
793 HEART RATE INCREASED 439 0.0044
794 CONJUNCTIVITIS 82 0.0044
795 LOWER RESPIRATORY TRACT INFECTION 201 0.0044
796 HIATUS HERNIA 57 0.0044
797 CONDITION AGGRAVATED 1332 0.0044
798 RENAL DISORDER 200 0.0043
799 PANCREATITIS 226 0.0043
800 FULL BLOOD COUNT DECREASED 86 0.0043
801 TOOTHACHE 77 0.0042
802 ADVERSE REACTION 56 0.0042
803 EOSINOPHILIA 74 0.0042
804 MUSCLE ATROPHY 53 0.0042
805 MALAISE 1808 0.0041
806 ABDOMINAL DISTENSION 429 0.0041
807 IMMUNODEFICIENCY 61 0.0041
808 VERTIGO 246 0.0040
809 PAIN IN JAW 114 0.0040
810 OSTEOPENIA 61 0.0040
811 HIP ARTHROPLASTY 61 0.0040
812 CARDIOVASCULAR DISORDER 101 0.0040
813 BLINDNESS 162 0.0040
814 NEOPLASM MALIGNANT 262 0.0039
815 ILL-DEFINED DISORDER 236 0.0039
816 PROSTATIC SPECIFIC ANTIGEN INCREASED 53 0.0038
817 DYSPEPSIA 378 0.0038
818 ANGIOEDEMA 169 0.0038
819 QUALITY OF LIFE DECREASED 51 0.0038
820 IMMUNE SYSTEM DISORDER 50 0.0038
821 UPPER RESPIRATORY TRACT INFECTION 175 0.0038
822 LOCAL SWELLING 66 0.0038
823 PRODUCT USE ISSUE 707 0.0038
824 BLOOD PRESSURE SYSTOLIC INCREASED 73 0.0037
825 CORONARY ARTERY DISEASE 113 0.0037
826 ABDOMINAL PAIN UPPER 768 0.0037
827 COVID-19 651 0.0037
828 TRANSIENT ISCHAEMIC ATTACK 125 0.0037
829 HEPATIC CIRRHOSIS 69 0.0037
830 RHABDOMYOLYSIS 153 0.0037
831 DIALYSIS 52 0.0037
832 RETCHING 78 0.0037
833 COMA 174 0.0037
834 ULCER 58 0.0036
835 HAEMATOCHEZIA 199 0.0036
836 CONVULSION 206 0.0036
837 COORDINATION ABNORMAL 50 0.0036
838 PRODUCT PRESCRIBING ISSUE 78 0.0036
839 PHOTOSENSITIVITY REACTION 59 0.0036
840 BLOOD POTASSIUM INCREASED 58 0.0036
841 CHOLELITHIASIS 116 0.0035
842 OROPHARYNGEAL PAIN 327 0.0035
843 HYPOACUSIS 152 0.0035
844 APHONIA 49 0.0035
845 FLUID OVERLOAD 51 0.0035
846 FEELING COLD 95 0.0034
847 CHROMATURIA 77 0.0034
848 DRUG INEFFECTIVE 4483 0.0034
849 FUNGAL INFECTION 113 0.0034
850 WHEEZING 201 0.0034
851 BLOOD PRESSURE ABNORMAL 67 0.0034
852 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 86 0.0033
853 NECK PAIN 186 0.0033
854 RIB FRACTURE 68 0.0033
855 BRADYCARDIA 175 0.0033
856 PALPITATIONS 386 0.0033
857 ORAL HERPES 64 0.0033
858 DRY MOUTH 266 0.0033
859 DIZZINESS 1617 0.0032
860 RASH MACULAR 113 0.0032
861 THROAT IRRITATION 145 0.0032
862 RESTLESSNESS 118 0.0032
863 NIGHT SWEATS 103 0.0032
864 CARDIAC FAILURE CONGESTIVE 255 0.0032
865 SKIN EXFOLIATION 267 0.0032
866 LACTIC ACIDOSIS 102 0.0031
867 HEART RATE IRREGULAR 71 0.0031
868 DRUG EFFECT INCOMPLETE 114 0.0031
869 ARTHRALGIA 1304 0.0031
870 VISUAL ACUITY REDUCED 104 0.0031
871 RASH GENERALISED 80 0.0031
872 DRY EYE 154 0.0031
873 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 89 0.0030
874 URTICARIA 509 0.0030
875 BLOOD PRESSURE INCREASED 448 0.0029
876 HYPOGLYCAEMIA 141 0.0029
877 SPEECH DISORDER 152 0.0029
878 ANXIETY 816 0.0029
879 PAIN IN EXTREMITY 836 0.0028
880 BRONCHITIS 209 0.0028
881 ADVERSE EVENT 260 0.0028
882 PAIN 1715 0.0028
883 CEREBROVASCULAR ACCIDENT 471 0.0028
884 PRURITUS GENERALISED 60 0.0028
885 LIP SWELLING 92 0.0028
886 POLLAKIURIA 115 0.0028
887 EAR PAIN 53 0.0027
888 FAECES DISCOLOURED 59 0.0027
889 BALANCE DISORDER 235 0.0027
890 RHINORRHOEA 172 0.0027
891 TYPE 2 DIABETES MELLITUS 89 0.0026
892 LABORATORY TEST ABNORMAL 78 0.0026
893 RASH PAPULAR 59 0.0026
894 DIABETES MELLITUS 198 0.0026
895 PRESCRIBED OVERDOSE 50 0.0026
896 EMOTIONAL DISTRESS 310 0.0026
897 LIMB DISCOMFORT 78 0.0025
898 WOUND 70 0.0025
899 AGITATION 183 0.0025
900 MOVEMENT DISORDER 80 0.0025
901 SWELLING FACE 161 0.0025
902 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 445 0.0025
903 ECZEMA 129 0.0025
904 GASTROOESOPHAGEAL REFLUX DISEASE 198 0.0025
905 MYOCARDIAL INFARCTION 424 0.0024
906 CHRONIC KIDNEY DISEASE 184 0.0024
907 VAGINAL HAEMORRHAGE 105 0.0024
908 GAIT DISTURBANCE 456 0.0024
909 INTERVERTEBRAL DISC PROTRUSION 52 0.0024
910 FOETAL EXPOSURE DURING PREGNANCY 192 0.0024
911 BLISTER 132 0.0023
912 AGEUSIA 58 0.0023
913 DISCOMFORT 141 0.0023
914 DRY SKIN 298 0.0022
915 VISUAL IMPAIRMENT 276 0.0022
916 SKIN DISCOLOURATION 101 0.0022
917 OSTEOPOROSIS 90 0.0022
918 GAIT INABILITY 73 0.0022
919 HEADACHE 1360 0.0022
920 ARTHRITIS 170 0.0022
921 VISION BLURRED 296 0.0022
922 OSTEOARTHRITIS 91 0.0021
923 SWOLLEN TONGUE 67 0.0021
924 VIRAL INFECTION 71 0.0021
925 COLITIS ULCERATIVE 94 0.0021
926 SOMNOLENCE 417 0.0021
927 TREMOR 343 0.0021
928 GASTRIC CANCER 52 0.0021
929 ABDOMINAL DISCOMFORT 336 0.0020
930 FALL 666 0.0020
931 DISTURBANCE IN ATTENTION 107 0.0020
932 CATARACT 117 0.0020
933 FEMUR FRACTURE 60 0.0019
934 DEPRESSED MOOD 102 0.0019
935 EXPOSURE DURING PREGNANCY 116 0.0019
936 DEPRESSION 419 0.0018
937 INSOMNIA 489 0.0018
938 ADVERSE DRUG REACTION 164 0.0018
939 FLUID RETENTION 92 0.0018
940 SYSTEMIC LUPUS ERYTHEMATOSUS 64 0.0018
941 SWELLING 167 0.0018
942 NASAL CONGESTION 104 0.0018
943 CONTUSION 170 0.0018
944 HEART RATE DECREASED 62 0.0018
945 DYSSTASIA 50 0.0017
946 BURNING SENSATION 120 0.0017
947 MATERNAL EXPOSURE DURING PREGNANCY 152 0.0017
948 BLOOD GLUCOSE INCREASED 316 0.0017
949 MOBILITY DECREASED 120 0.0017
950 PERIPHERAL SWELLING 248 0.0016
951 OCULAR HYPERAEMIA 76 0.0016
952 MUSCLE SPASMS 293 0.0016
953 FLATULENCE 89 0.0016
954 ARTHROPATHY 86 0.0015
955 SLEEP DISORDER 107 0.0015
956 INFLUENZA LIKE ILLNESS 123 0.0015
957 BREAST CANCER 139 0.0015
958 CARDIAC DISORDER 138 0.0015
959 SURGERY 84 0.0014
960 TREATMENT NONCOMPLIANCE 74 0.0014
961 SINUSITIS 137 0.0013
962 AMNESIA 82 0.0013
963 MUSCULOSKELETAL STIFFNESS 110 0.0013
964 THERAPY CESSATION 64 0.0012
965 INFLUENZA 138 0.0012
966 HALLUCINATION 93 0.0012
967 MEMORY IMPAIRMENT 169 0.0012
968 NEPHROLITHIASIS 55 0.0012
969 MEDICATION ERROR 66 0.0012
970 AGGRESSION 58 0.0012
971 FEELING ABNORMAL 271 0.0011
972 UNEVALUABLE EVENT 85 0.0011
973 NO ADVERSE EVENT 201 0.0011
974 ASTHMA 124 0.0011
975 WEIGHT INCREASED 244 0.0011
976 INJURY 76 0.0011
977 RHEUMATOID ARTHRITIS 122 0.0011
978 PROSTATE CANCER 86 0.0011
979 EYE PAIN 60 0.0011
980 UNDERDOSE 70 0.0010
981 PSORIASIS 119 0.0009
982 NASOPHARYNGITIS 160 0.0009
983 JOINT SWELLING 104 0.0009
984 SKIN BURNING SENSATION 61 0.0009
985 ACNE 63 0.0008
986 THERAPY INTERRUPTED 58 0.0008
987 DEVICE MALFUNCTION 54 0.0008
988 MIGRAINE 70 0.0007
989 HOSPITALISATION 100 0.0007
990 OVERDOSE 125 0.0006
991 ILLNESS 59 0.0006
992 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 111 0.0005
993 INCORRECT DOSE ADMINISTERED 100 0.0004
994 PRODUCT DOSE OMISSION ISSUE 72 0.0002
995 INJECTION SITE PAIN 60 0.0002